Literature DB >> 20047081

Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population.

Mikkel Andreassen1, Ilan Raymond, Per Hildebrandt, Caroline Kistorp, Camilla Rathcke, Henrik Vestergaard, Jens Faber, Lars Ostergaard Kristensen.   

Abstract

BACKGROUND AND
OBJECTIVE: The objective of the present study was to test the hypothesis that circulating levels of insulin-like growth factor-I (IGF-I) are inversely associated with inflammatory processes in an elderly background population. PATIENTS AND
DESIGN: We conducted a population-based study comprising 629 individuals, aged 50-89 years. Associations between plasma IGF-I versus interleukin 6 (IL-6) and the acute phase proteins high sensitive C-reactive protein (hsCRP) and YKL-40 were evaluated by linear regression analyses. Subsequently, the population was dichotomised at a CRP level of 3.0 mg/L and the associations were re-evaluated in the two subgroups.
RESULTS: Adjusted for confounding variables, plasma IGF-I was inversely related to IL-6, hsCRP and YKL-40 (all P < 0.001). The strongest association was found for YKL-40 with a 34% reduction in YKL-40 per twofold increase in IGF-I. A significant inverse association between IGF-I and all markers of inflammation persisted in individuals with hsCRP below 3.0 mg/L whereas only YKL-40 was significantly associated with IGF-I in individuals with hsCRP above 3.0 mg/L.
CONCLUSIONS: The data support the hypothesis of an inverse association between GH/IGF-I signalling and inflammation, and suggest that the relationship between the IGF-I and inflammation might be more predominant in healthy individuals with a low inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20047081     DOI: 10.1007/s00011-009-0154-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  40 in total

Review 1.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

Authors:  W B Ershler; E T Keller
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

Review 2.  Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

Authors:  Anders Juul
Journal:  Growth Horm IGF Res       Date:  2003-08       Impact factor: 2.372

Review 3.  Immune dysregulation and chronic stress among older adults: a review.

Authors:  Jean-Philippe Gouin; Liisa Hantsoo; Janice K Kiecolt-Glaser
Journal:  Neuroimmunomodulation       Date:  2008-11-26       Impact factor: 2.492

4.  Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons.

Authors:  Michelangela Barbieri; Luigi Ferrucci; Emilia Ragno; Annamaria Corsi; Stefania Bandinelli; Massimiliano Bonafè; Fabiola Olivieri; Simona Giovagnetti; Claudio Franceschi; Jack M Guralnik; Giuseppe Paolisso
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11-05       Impact factor: 4.310

Review 5.  Growth hormone as a cytokine.

Authors:  M J Waters; C A Shang; S N Behncken; S P Tam; H Li; B Shen; P E Lobie
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-10       Impact factor: 2.557

6.  Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis.

Authors:  A Lemmey; P Maddison; A Breslin; P Cassar; N Hasso; R McCann; E Whellams; J Holly
Journal:  J Rheumatol       Date:  2001-01       Impact factor: 4.666

7.  Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.

Authors:  Gemma Sesmilo; Wesley P Fairfield; Laurence Katznelson; Karen Pulaski; Pamela U Freda; Vivien Bonert; Eleni Dimaraki; Stavros Stavrou; Mary Lee Vance; Douglas Hayden; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

8.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.

Authors:  Sean X Leng; Anne R Cappola; Ross E Andersen; Marc R Blackman; Kathleen Koenig; Michael Blair; Jeremy D Walston
Journal:  Aging Clin Exp Res       Date:  2004-04       Impact factor: 3.636

9.  IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population.

Authors:  Mikkel Andreassen; Ilan Raymond; Caroline Kistorp; Per Hildebrandt; Jens Faber; Lars Østergaard Kristensen
Journal:  Eur J Endocrinol       Date:  2008-10-17       Impact factor: 6.664

10.  Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen.

Authors:  I Raymond; F Pedersen; F Steensgaard-Hansen; A Green; M Busch-Sorensen; C Tuxen; J Appel; J Jacobsen; D Atar; P Hildebrandt
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

View more
  4 in total

1.  The Independent Role of Inflammation in Physical Frailty among Older Adults with Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.

Authors:  L Tay; W S Lim; M Chan; R J Ye; M S Chong
Journal:  J Nutr Health Aging       Date:  2016-03       Impact factor: 4.075

2.  YKL-40 A Sensitive Biomarker for Early Androgenetic Alopecia and Early Hidden Metabolic Syndrome.

Authors:  Doaa M Elhabak; Walid Abdel Abdel Halim
Journal:  Int J Trichology       Date:  2020-05-05

3.  Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations.

Authors:  A H Gifford; A B Nymon; A Ashare
Journal:  Pediatr Pulmonol       Date:  2013-06-18

4.  Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females.

Authors:  Silvia Savastano; Carolina Di Somma; Genoveffa Pizza; Annalba De Rosa; Valeria Nedi; Annalisa Rossi; Francesco Orio; Gaetano Lombardi; Annamaria Colao; Giovanni Tarantino
Journal:  J Transl Med       Date:  2011-08-16       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.